Literature DB >> 10534206

Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease.

M R Howell1, J C Gaydos, K T McKee, T C Quinn, C A Gaydos.   

Abstract

CONTEXT: Chlamydia trachomatis genitourinary infections in females can lead to serious and costly sequelae. Programs such as basic (initial entry) military training with controlled points of entry offer an opportunity to screen large cohorts of women at risk for infection.
OBJECTIVE: To assess the cost-effectiveness of three interventions for C. trachomatis infections in women beginning Army training: 1) screening using urine ligase chain reaction (LCR) by age, 2) unrestricted testing using urine LCR, and 3) universal antibiotic treatment with azithromycin.
DESIGN: Cost-effectiveness analysis from a military perspective. SETTING AND PATIENTS: A hypothetical cohort of 10,000 women who intended to complete at least 2 years of military service was studied. Analysis was based on data from 13,204 female trainees screened for chlamydial infection at Fort Jackson, SC. OUTCOMES: Program and training costs, cost of illness averted, and pelvic inflammatory disease (PID) prevented were determined for a 1-year follow-up period. Using sensitivity analysis, outcomes over 2 years were studied.
RESULTS: At a 9.2% prevalence, no screening resulted in $220,900 in training and sequelae costs and 276 cases of PID. Screening by age produced the lowest cost $217,600, over a 1-year period and prevented 222 cases of PID for a cost-savings of $15 per case of PID prevented. Universal testing prevented an additional 11 cases of PID at a cost of $226,400, or costing $800 per additional case of PID prevented over age-targeted screening. Universal treatment prevented an additional 32 cases of PID and cost $221,100, saving $167 per additional cases of PID prevented over universal screening. Over a 2-year period, universal treatment provided the highest cost-savings and prevented the most disease.
CONCLUSION: Screening by age provided a cost-savings to the Army over a 1-year period. Other organizations accessing large cohorts of young women could also benefit, even in the short term, from implementation of an age-based chlamydial screening program. Universal testing or universal treatment may be warranted in which long-term societal goals, such as maximum reduction of PID, are relevant.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10534206     DOI: 10.1097/00007435-199910000-00007

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  13 in total

Review 1.  Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies.

Authors:  E Honey; C Augood; A Templeton; I Russell; J Paavonen; P-A Mårdh; A Stary; B Stray-Pedersen
Journal:  Sex Transm Infect       Date:  2002-12       Impact factor: 3.519

2.  Provider willingness to screen all sexually active adolescents for chlamydia.

Authors:  B O Boekeloo; M H Snyder; M Bobbin; G R Burstein; D Conley; T C Quinn; J M Zenilman
Journal:  Sex Transm Infect       Date:  2002-10       Impact factor: 3.519

Review 3.  One to one interventions to reduce sexually transmitted infections and under the age of 18 conceptions: a systematic review of the economic evaluations.

Authors:  L Barham; D Lewis; N Latimer
Journal:  Sex Transm Infect       Date:  2007-07-11       Impact factor: 3.519

Review 4.  Better tests, better care: improved diagnostics for infectious diseases.

Authors:  Angela M Caliendo; David N Gilbert; Christine C Ginocchio; Kimberly E Hanson; Larissa May; Thomas C Quinn; Fred C Tenover; David Alland; Anne J Blaschke; Robert A Bonomo; Karen C Carroll; Mary Jane Ferraro; Lisa R Hirschhorn; W Patrick Joseph; Tobi Karchmer; Ann T MacIntyre; L Barth Reller; Audrey F Jackson
Journal:  Clin Infect Dis       Date:  2013-12       Impact factor: 9.079

Review 5.  Screening for Chlamydia trachomatis: a systematic review of the economic evaluations and modelling.

Authors:  T E Roberts; S Robinson; P Barton; S Bryan; N Low
Journal:  Sex Transm Infect       Date:  2006-06       Impact factor: 3.519

6.  Multicenter evaluation of the BDProbeTec ET System for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs.

Authors:  B Van Der Pol; D V Ferrero; L Buck-Barrington; E Hook; C Lenderman; T Quinn; C A Gaydos; J Lovchik; J Schachter; J Moncada; G Hall; M J Tuohy; R B Jones
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

7.  The Use of Urine and Self-obtained Vaginal Swabs for the Diagnosis of Sexually Transmitted Diseases.

Authors:  Charlotte A. Gaydos; Anne M. Rompalo
Journal:  Curr Infect Dis Rep       Date:  2002-04       Impact factor: 3.725

8.  Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens.

Authors:  C A Gaydos; T C Quinn; D Willis; A Weissfeld; E W Hook; D H Martin; D V Ferrero; J Schachter
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

9.  Cost-effectiveness of screening strategies for Chlamydia trachomatis using cervical swabs, urine, and self-obtained vaginal swabs in a sexually transmitted disease clinic setting.

Authors:  Diane R Blake; Nancy Maldeis; Mathilda R Barnes; Andrew Hardick; Thomas C Quinn; Charlotte A Gaydos
Journal:  Sex Transm Dis       Date:  2008-07       Impact factor: 2.830

10.  The changing landscape of controlling sexually transmitted infections in the U.S. military.

Authors:  Joel C Gaydos; Kelly T McKee; Charlotte A Gaydos
Journal:  MSMR       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.